PRESS RELEASE published on 04/18/2025 at 09:24, 9 months 10 days ago Inside Information / Other news releases Sensorion provides preliminary documents for the Combined Shareholders' General Meeting of May 12, 2025 at Hotel Square Louvois, Paris. Shareholders can request meeting documents and view details on company website Shareholders' Meeting General Meeting Preliminary Documents Sensorion Hearing Loss
BRIEF published on 04/16/2025 at 07:35, 9 months 12 days ago Sensorion is organizing a symposium at the ISIET 2025 conference Gene Therapy Hearing Loss SENS-401 Medical Innovations Sensorion Symposium
PRESS RELEASE published on 04/16/2025 at 07:30, 9 months 12 days ago Inside Information / Other news releases Sensorion to host a symposium at ISIET's International Conference on Inner Ear Therapies in Marrakech, Morocco, on April 26, 2025, focusing on hearing loss innovation and gene therapies Sensorion Gene Therapies Symposium ISIET Inner Ear Therapies
BRIEF published on 04/02/2025 at 07:35, 9 months 26 days ago Sensorion Appoints Amit Munshi as Chairman of the Board Board Of Directors Hearing Loss Therapies Sensorion Leadership Amit Munshi Appointment Biotech Executive Experience
PRESS RELEASE published on 04/02/2025 at 07:30, 9 months 26 days ago Inside Information / Other news releases Sensorion appoints Amit Munshi as Chairman of the Board and Independent Director, bringing extensive healthcare industry experience. Munshi to lead innovative therapeutic programs for hearing disorders Chairman Board Sensorion Amit Munshi Hearing Disorders
BRIEF published on 03/26/2025 at 07:35, 10 months 2 days ago Sensorion joins the Van Lanschot Kempen conference in Amsterdam Investors Biotechnology Conference Sensorion Hearing Loss
PRESS RELEASE published on 03/26/2025 at 07:30, 10 months 2 days ago Inside Information / Other news releases Sensorion announces participation at Van Lanschot Kempen Conference Life Sciences in Amsterdam on April 2-3, 2025. Company focuses on developing therapies for hearing loss disorders Life Sciences Sensorion Amsterdam Hearing Loss Therapies Van Lanschot Kempen Conference
BRIEF published on 03/14/2025 at 07:35, 10 months 14 days ago Sensorion: 2024 Review and Outlook for 2025 Financial Results Investments SENS-401 SENS-501 Gene Therapies
PRESS RELEASE published on 03/14/2025 at 07:30, 10 months 14 days ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
BRIEF published on 03/07/2025 at 07:35, 10 months 21 days ago Sensorion Completes Recruitment for NOTOXIS Trial of SENS-401 Clinical Trial Sensorion SENS-401 Cisplatin Ototoxicity
Published on 01/29/2026 at 03:30, 3 hours 32 minutes ago NuRAN Provides Clarification and Corrections Regarding Restructuring Transaction Disclosure
Published on 01/29/2026 at 02:15, 4 hours 47 minutes ago McEwen Inc. to Acquire Golden Lake Exploration Inc.
Published on 01/29/2026 at 01:50, 5 hours 12 minutes ago Alphinat Announces a Net Profit of $89,282 for Quarter Ended November 30, 2025
Published on 01/29/2026 at 00:00, 7 hours 2 minutes ago Tokenwell Adds Single-Coin Trading Capabilities and Expands Exchange Support
Published on 01/28/2026 at 23:45, 7 hours 17 minutes ago CoTec Holdings Corp. Announces Warrant Exercise by Kings Chapel
Published on 01/29/2026 at 06:58, 4 minutes ago After Record Year: DWS Exceeds Strategic Mid-term Targets and Increases Ambitions Until 2028
Published on 01/29/2026 at 06:57, 5 minutes ago Emmi continues its growth dynamic and convinces with innovative strength
Published on 01/29/2026 at 06:50, 12 minutes ago Piramal Pharma Limited Announces Results for Q3 and 9M FY26
Published on 01/28/2026 at 18:00, 13 hours 2 minutes ago Launch of Skira Education Systems and acquisition of Institut Beau Cèdre
Published on 01/28/2026 at 17:45, 13 hours 17 minutes ago Infotel : Q4 2025 revenue up +3.5%. Acquisition of Sesin, a specialist in EDM. A promising start to 2026
Published on 01/28/2026 at 17:40, 13 hours 22 minutes ago Mersen: Sales of €1.2 billion in 2025, in line with expectations
